| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 08/21/2008 | WO2008098851A1 Electroluminescent metal complex |
| 08/21/2008 | WO2008064217A9 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and pharmaceutical formulations thereof |
| 08/21/2008 | US20080200678 Metallic Compound and Organic Electroluminescence Device Comprising the Same |
| 08/21/2008 | US20080200669 Synthesis of such as 4-(3,3'-Dihydroxybiphenyl-4-yl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-1-phenylazetidin-2-one; cholesterol absorption inhibitors |
| 08/21/2008 | US20080200551 Flourene Derivative |
| 08/21/2008 | CA2676944A1 2-aminooxazolines as taar1 ligands |
| 08/20/2008 | EP1958941A1 Oxazolidinones and their use as hypocholesterolemic agents |
| 08/20/2008 | EP1958940A1 Condensation reaction by metal catalyst |
| 08/20/2008 | EP1957470A1 Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols |
| 08/20/2008 | EP1957459A2 Iminopropene compound and use thereof |
| 08/20/2008 | EP1957448A1 Substituted azacycloalkanes useful for treating cns conditions |
| 08/20/2008 | EP1957058A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 08/20/2008 | EP1660492B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 08/20/2008 | EP1587821B1 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 08/20/2008 | CN101248053A N-oxides as prodrugs of piperazine and piperidine derivatives |
| 08/20/2008 | CN101248052A Antagonists of the vanilloid receptor subtype 1 (vr1) and use thereof |
| 08/19/2008 | US7414138 e.g. 2-cyano-3-{4-[5-tert.-butyl-benzoxazol-2-yl]-phenyl}-acrylic acid 2-ethylhexyl ester; protecting human skin or human hair, and plastic material or a medicinal product that is sensitive to UV radiation from UV-A irradiation; antiaging |
| 08/19/2008 | US7414064 Pesticides for crops; agriculture, horticulture |
| 08/19/2008 | US7414046 Gyrase inhibitors and uses thereof |
| 08/14/2008 | WO2008096149A2 Napadisylate salt of a muscarinic m3 antagonist |
| 08/14/2008 | WO2008096143A1 Napadisylate salt of a muscarinic m3 antagonist |
| 08/14/2008 | WO2008096128A1 Oxazole and thiazole derivatives and their uses 2 |
| 08/14/2008 | WO2008096093A1 Oxazole and thiazole derivatives and their uses |
| 08/14/2008 | US20080194833 Process For Production of Optically Active Ppar-Activating Compound and Intermediate of the Same |
| 08/14/2008 | US20080194816 Method of producing an o-disubstituted aromatic compound, and method of producing a monosubstituted-monohaloaromatic compound |
| 08/14/2008 | US20080194782 Solid, hydrocarbon-insoluble, catalyst component containing magnesium, titanium, and halogen, and further contains an internal electron donor which does not contain a phthalate derivative, for example, ethyl (phenylacetoxy)acetate; stereospecific polymerization; highly crystalline propylene polymers |
| 08/14/2008 | US20080194608 Atherosclerosis therapy; antidiabetic agents; dyslipidemia |
| 08/14/2008 | CA2675629A1 New salt |
| 08/13/2008 | EP1956013A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 08/13/2008 | EP1956012A1 Method for producing 2-oxazoline analogue or 1,3-oxazine analogue |
| 08/13/2008 | EP1954684A2 Oxazole compound and pharmaceutical composition |
| 08/13/2008 | EP1954681A2 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 08/13/2008 | EP1828177B1 Novel mch receptor antagonists |
| 08/13/2008 | EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 08/13/2008 | EP1452528B1 Xanthine oxidase inhibitors |
| 08/13/2008 | CN101239994A Transition metal complex having diphosphine compound as ligand |
| 08/13/2008 | CN101239993A Transition metal complex having diphosphine compound as ligand |
| 08/13/2008 | CN101239992A Transition metal complex having diphosphine compound as ligand |
| 08/13/2008 | CN101239991A Transition metal complex having diphosphine compound as ligand |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/07/2008 | WO2008092785A1 Novel 2-aminooxazolines as taar1 ligands for cns disorders |
| 08/07/2008 | WO2008070111A3 Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
| 08/07/2008 | US20080188667 Azlactone compound and method for preparation thereof |
| 08/07/2008 | US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 08/07/2008 | US20080188489 Cell differentiation inducer |
| 08/07/2008 | CA2675221A1 Novel 2-aminooxazolines as taar1 ligands |
| 08/06/2008 | EP1951719A2 Certain chemical entities, compositions, and methods |
| 08/06/2008 | EP1951701A2 Ep2 receptor agonists |
| 08/06/2008 | EP1951692A1 Oxazole and thiazole ppar modulator |
| 08/06/2008 | EP1951217A2 Chemical compounds |
| 08/06/2008 | EP1660491B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 08/06/2008 | EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 08/06/2008 | EP1397341B1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 08/06/2008 | EP1385379B1 Insecticide and method of controlling insects |
| 08/06/2008 | CN101238110A Heterocyclic compounds as agonists for the thyroid receptor |
| 08/06/2008 | CN100408553C Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate of the same |
| 08/05/2008 | US7408076 2-Bromoanaline and 2-chloroaniline compounds |
| 08/05/2008 | US7407976 Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters |
| 08/05/2008 | US7407975 Epothilone derivatives, method for producing same and their pharmaceutical use |
| 08/05/2008 | US7407960 e.g. 2-{4-[(2R)-2-hydroxy-3-(2-methylbenzothiazol-5-yloxy)propyl]piperazinyl}-N-((1S)-1-phenylethyl)acetamide; fatty acid oxidation inhibitor; cardiovascular diseases: atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's angina, stable and unstable angina, and diabetes |
| 08/05/2008 | US7407950 N-(heteroaryl)-1H-indole-2-carboxamide derivatives and their use as vanilloid TRPV1 receptor ligands |
| 08/05/2008 | US7407648 Protecting human and animal hair or skin from UV radiation by applying a 4,4-disubstituted -1,3-butadienylamine; 4,4-substituents may be the same or different and are cyano, ester, sec. or tert. amide, ketone and/or sulfone, e.g., 4,4-bis(hexyloxycarbonyl)-N,N-diethyl-1,3-butadienylamine |
| 08/05/2008 | CA2314514C Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents |
| 07/31/2008 | WO2008090382A1 Thiazole and oxazole derivatives for use in the treatment of prion diseases, cancer and conditions of the central nervous system as well as in the regulation of stem cells |
| 07/30/2008 | EP1948711A1 Cyclocarbonate-containing energy-curable compositions |
| 07/30/2008 | EP1948649A2 Fungicidal carboxamides |
| 07/30/2008 | EP1948594A1 Process for the synthesis of intermediates of chloramphenicol or its analogues |
| 07/30/2008 | EP1041977B1 Use of ppar-gamma activators for treating dermatological disorders |
| 07/30/2008 | CN101233119A Novel heterocyclic nf-kb inhibitors |
| 07/30/2008 | CN101230048A 3-amido-2-oxazolidinone derivative hapten and method for preparing same |
| 07/30/2008 | CN101230047A Method for preparing 4-substituted chirality oxazolidinone compounds |
| 07/30/2008 | CN101230008A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/30/2008 | CN101229166A Therapeutic agent for keratoconjunctival disorder |
| 07/30/2008 | CN100406446C Benzoxazole derivatives and their use as adenosine receptor ligands |
| 07/30/2008 | CN100405910C Insecticide and method of controlling insects |
| 07/29/2008 | US7405212 Helix mimetics and composition and methods related thereto |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2337755C Inhibitors of p38 |
| 07/29/2008 | CA2175767C Adhesion receptor antagonists |
| 07/24/2008 | WO2007127473A3 Poly (ethylene glycol) containing chemically disparate endgroups |
| 07/24/2008 | WO2007120638A3 Methods and compositions for modulating glycosylation |
| 07/24/2008 | US20080177080 Oxazole derivatives of tetracyclines |
| 07/24/2008 | US20080177079 Reacting 2-fluoropropionic acid to 2-fluoropropionyl chloride; reacting with pyrrolidine to form N-(2-fluoropropionyl)pyrrolidine; N-(2-fluoropropionyl)benzoxazolinone; chemical intermediates for 1-(2-deoxy-2-fluoro-2-C-methyl- beta -D-ribofuranosyl)cytosine antihepatitis C virus agents; concentration |
| 07/24/2008 | US20080176914 Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 07/24/2008 | US20080176912 Gpr40 agonists |
| 07/24/2008 | US20080176899 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders |
| 07/24/2008 | US20080176842 N1-[1-[N-(2-methylpropyl)-N-(phenylsulfonyl)amino]-2R-hydroxy-3S-(phenylmethyl)prop-3-yl]-3-(1-morpholinosulfonyl)-2R-methylpropionamide; viricide; human T-cell leukemia/limphoma virus |
| 07/23/2008 | EP1945620A2 Compounds and compositions as ppar modulators |
| 07/23/2008 | EP1945609A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/23/2008 | EP1945208A2 Composition and synthesis of new reagents for inhibition of hiv replication |
| 07/23/2008 | EP1827427B1 Aryloxyethylamine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 07/23/2008 | EP1551814B1 Chirale oxazole-arylpropionic acid derivatives and their use as ppar agonists |
| 07/23/2008 | CN101228140A Imidazole-amino acid derivatives and related compounds synthetic method |
| 07/23/2008 | CN101228133A Heteroaroyl-substituted serineamides |
| 07/22/2008 | US7402671 UV excitable fluorescent energy transfer dyes |
| 07/22/2008 | US7402605 E.g., 17,17-propano-16-hydroxy-5-(4-ethoxycarbonylthiazol-2-yl)-9-oxo-1,2,3,4,20-pentanor-5-thia-8-azaprost-13-ene; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 07/22/2008 | US7402548 Benzoxazole compounds, process for producing the same and herbicides |
| 07/22/2008 | CA2436942C Method of manufacturing substance gm-95 |
| 07/22/2008 | CA2372840C Substituted bicyclic compounds |
| 07/22/2008 | CA2343346C Process for the preparation of 4,5-diamino shikimic acid derivatives |